[Articles] Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial

Journal content Created on 11 Jul 2026 The Lancet Oncology

• Details
• • All feed content
  • My feed content